Overview and definition
A phlebolith is a calcified intravascular thrombus that forms within slow-flow venous channels, and in the oral and maxillofacial region it is almost always a marker of an underlying venous malformation rather than an independent disease.[1][2] It is benign and non-neoplastic. Formation reflects blood stasis within valveless, ectatic venous channels, which promotes recurrent thrombosis and localized intravascular coagulation; microthrombi adhere to the abnormal endothelium and mineralize from their inner layers until the organized, calcified nodule is freed into the lumen.[1][2]
The usual location is the soft tissue of the face and neck, particularly the muscles of mastication, lip, tongue, buccal space, and submandibular region, mirroring the distribution of venous malformations.[3] The signature imaging appearance is one or more small, rounded, laminated calcifications with a radiolucent core, often multiple and scattered within a compressible soft-tissue mass.[4][5] Because the phlebolith is a clue to a venous malformation, management is directed at the parent lesion, and recognition chiefly serves to avoid misdiagnosis as a salivary stone and to prevent ill-advised biopsy of a vascular lesion.[6][7]
Terminology and classification
A phlebolith is literally a "vein stone"—an organized, calcified venous thrombus.[8] In current practice it is best understood through the International Society for the Study of Vascular Anomalies (ISSVA) classification, which separates vascular tumors from vascular malformations and places venous malformations among the simple, slow-flow malformations in which phleboliths characteristically arise.[1][2]
A persistent terminology pitfall is the historical use of "cavernous hemangioma" for what are now recognized as venous malformations; venous malformations are present at birth, grow with the patient, and do not involute, unlike infantile hemangioma, and conflating the two remains a documented source of nosologic confusion.[9][10] For the maxillofacial clinician, the practical point is that "phlebolith" names the calcification, while the correct lesional diagnosis is the venous malformation that contains it.
Epidemiology
Venous malformations are the most common vascular malformation, present in roughly 1% of the population, with approximately 40% occurring in the head and neck; most (over 90%) are sporadic and unifocal.[3][11] Phleboliths are a common intralesional finding within these malformations, especially larger and longer-standing lesions, and their presence correlates with localized intravascular coagulation.[1][12]
As an incidental maxillofacial finding, however, phleboliths are rare relative to other soft-tissue calcifications. In surveys of maxillofacial imaging they are far less frequent than tonsilloliths, calcified stylohyoid ligaments, or calcified atheromas, with reported detection on the order of a fraction of a percent.[13][14] There is no strong sex predilection. Venous malformations are congenital but frequently present later in life, and calcification burden tends to increase with lesion size and patient age.[1][3]
Clinical presentation
- Typical presentation: a soft, non-pulsatile, compressible bluish mass that enlarges with dependency, Valsalva, or increased central venous pressure and decompresses with elevation. Intraoral lesions on the lip, buccal mucosa, or tongue appear as bluish submucosal swellings.[2][3][11][15]
- Symptoms from the phlebolith itself: episodic pain, tenderness, and localized swelling from thrombosis, with palpable firm intralesional nodules; patients may report a foreign-body sensation.[1][3]
- Tempo: slow growth over years; more than 60% of venous malformations progress during adolescence, and expansion can be triggered by trauma, infection, or hormonal change.[3][11]
- Complications:localized intravascular coagulopathy (elevated D-dimer, low fibrinogen) with recurrent painful thrombosis; large tongue or pharyngeal lesions may cause speech, masticatory, or swallowing difficulty.[1][12][15]
- Red flags: mucosal and aerodigestive involvement with potential airway compromise and dysphagia; a vascular lesion should not be biopsied blindly, as venous malformations are recognized "do-not-touch" lesions diagnosable by imaging.[3][6][16]
Radiographic findings
Location and distribution
Phleboliths project over the soft tissues of the face and neck, commonly overlying the mandibular ramus, body, or angle, the masseter/pterygoid region, the buccal space, and the submandibular region, following the distribution of the parent venous malformation.[3] A key discriminating feature is that they lie within a soft-tissue mass that is separate from the salivary glands and jawbones, and submandibular phleboliths characteristically lie outside the gland and its duct, scattered through the surrounding soft tissue.[4][7] They are frequently multiple, in contrast with the usually solitary sialolith.[4]
Relationship to teeth and the alveolar process
Phleboliths have no intrinsic relationship to the teeth or alveolus; they are soft-tissue calcifications superimposed on the jaws rather than arising from them.[4][5] This superimposition is the chief reason they are mistaken for odontogenic or salivary pathology on planar images, and correlation with the soft-tissue mass clarifies their extraosseous origin.[7]
Periphery and shape
Individual phleboliths are small, round to oval, and well-defined, and are characteristically smaller than sialoliths; the round-to-oval contour contrasts with the elongated, duct-shaped sialolith.[4][5] Well-defined round or oval calcifications of this type are considered essentially pathognomonic of a venous malformation when seen within a compatible soft-tissue mass.[5]
Internal architecture
The most useful internal feature is concentric lamellation with a central lucency—a laminated "target" or ring-like pattern produced by a radiolucent thrombotic core surrounded by denser calcified fibrous layers.[4][8] A central lucency, when present, is a useful discriminator; a rounded contour likewise strongly favors a phlebolith.[8] The lamellated core-and-rim appearance distinguishes them from the generally homogeneous density of a sialolith.[4]
Effects on adjacent structures
The calcifications themselves do not resorb teeth or erode cortex.[5] The underlying venous malformation, however, may produce reactive bony remodeling, cortical thickening, or periosteal reaction in adjacent bone when it abuts or involves the jaw.[5] True intraosseous vascular malformation of the jaw is a separate, more aggressive entity that produces osteolytic, "soap-bubble," or ground-glass change and widened marrow spaces, and should not be confused with soft-tissue phleboliths.[17]
Extent, number, and variants
Burden ranges from a solitary calcification to numerous scattered phleboliths throughout an extensive malformation, and multiple calcifications within a soft-tissue mass favor a venous malformation over a salivary stone—an especially valuable distinction in children.[7] Number and size tend to increase with the size and chronicity of the lesion.[1]
Other imaging findings
Cross-sectional characterization of the parent lesion
Beyond detecting the calcification, cross-sectional imaging defines the venous malformation and is decisive for management. On T2-weighted magnetic resonance imaging the malformation is a lobulated, markedly hyperintense ("venous lake") lesion, within which phleboliths appear as rounded signal voids on all sequences (calcification, not flow voids; venous malformations lack flow voids) and are more conspicuous on gradient-echo imaging; intralesional thrombi or phleboliths may also produce T1 hyperintensity.[5][10][18] MRI is the reference standard for mapping extent, tissue involvement, and airway relationships, and the signal-void phlebolith within a T2-bright lesion is a near-pathognomonic combination.[5][10]
Ultrasound and computed tomography
On ultrasound the lesion is a spongiform, compressible, hypoechoic mass with slow or undetectable Doppler flow, in which phleboliths appear as echogenic foci with posterior acoustic shadowing.[3][5][10] On computed tomography the malformation is an ill-defined, muscle-density lesion with progressive venous enhancement, and phleboliths are discrete calcifications that may show a central hypodense core.[6][19]
Differential diagnosis
Most diagnostic errors arise when a rounded facial or cervical calcification is attributed to a salivary stone and the underlying venous malformation is missed. Distinguishing features are the lamellated core-and-rim architecture, multiplicity, oval shape, extraglandular location, and association with a compressible soft-tissue mass.[4][7]
| Entity | Why it is considered | Best discriminator |
|---|---|---|
| Sialolith (submandibular) | Radiopaque calcification in the submandibular region with prandial swelling | Sialoliths are usually solitary, larger, elongated, and within gland or duct; phleboliths are multiple, smaller, round-to-oval, laminated with a lucent core, and outside the gland[4][7] |
| Calcified lymph node | Nodal calcification overlapping the mandible or neck, history of granulomatous disease | Irregular, granular/cauliflower density without concentric lamellation or central lucency[4][14] |
| Tonsillolith | Common oropharyngeal calcification projected over the ramus | Seated in the tonsillar fossa medial to the ramus, often clustered or bilateral, with no venous soft-tissue mass[13][20] |
| Calcified carotid artery atheroma | Calcification near the mandibular angle in older adults | Vertical location at the C3–C4 intervertebral level, a stroke risk marker, lacking lamellation[4][14] |
| Calcified stylohyoid ligament | Linear calcified band in the lateral neck | Elongated, segmented linear morphology following the ligament course rather than a rounded nodule[13] |
The highest-risk pitfall is operating on a presumed sialolith—particularly in a child, where true stones are uncommon—and thereby missing a venous malformation.[7] When calcifications are multiple, oval, laminated, or lie within a compressible mass separate from the gland, magnetic resonance imaging should confirm the venous malformation, and blind biopsy of the vascular lesion should be avoided.[6][7]
Histopathology
A phlebolith is an organized, calcified venous thrombus composed of laminated, calcified fibrous tissue, with a surface layer continuous with the vein endothelium; the concentric laminations correspond radiographically to the ring-and-lucent-core pattern.[8] The parent venous malformation consists of thin-walled, ectatic, dysmorphic venous channels lined by flat endothelium with deficient, disorganized smooth-muscle media, dissecting normal tissue, with interspersed thrombi in varying stages of organization and calcification.[2][19] On microscopy, phleboliths are seen as calcified foci within thrombosed channels of the malformation.[21]
Molecular correlation reinforces classification: most sporadic venous malformations harbor somatic activating variants in TEK (TIE2) or PIK3CA, driving PI3K/AKT/mTOR signaling, with germline TEK variants in familial cutaneomucosal forms.[2][9][19] These findings do not change the identity of the phlebolith itself but confirm the venous malformation as the parent lesion and underpin targeted medical therapy.[19]
Management and prognosis
- Workup and referral: confirm the venous malformation clinically and with magnetic resonance imaging, assess extent and airway, and refer to a vascular anomalies team; venous malformations are do-not-touch lesions that generally do not require biopsy, and pulsatile or clearly vascular lesions must not be biopsied.[6][16]
- Asymptomatic phleboliths: no treatment of the calcification is required; management addresses the parent lesion only when symptomatic.[15]
- Medical/pain control: NSAIDs and warm compresses for thrombophlebitic pain; low-dose aspirin to prevent or lessen painful thrombosis; low-molecular-weight heparin for coagulopathy or refractory venous-stasis pain; sirolimus for refractory pain, swelling, or coagulopathy.[3]
- Definitive treatment of the malformation:sclerotherapy (sodium tetradecyl sulfate, bleomycin, or ethanol) is the mainstay; airway protection is essential because head-and-neck venous malformations swell after sclerotherapy.[3][10][11]